7/27/2011

Covidien said it saw an increase in overall sales for its third fiscal quarter. The company, however, also saw a decrease in pharmaceutical sales owing to the sale of its nuclear pharmacies in the third quarter of last year and to lower sales of specialty pharmaceuticals.

Related Summaries